Amboy Street Ventures Fund II

Amboy Street Ventures

Status

ACTIVE

Global HQ

New York, United States

Countries of investment

Investment stages

Seed
Series A

Industries

Sexual Health
Women's Health
Femtech
Consumer Health
Telehealth
Diagnostics
Consumer Products
Digital Health

About
Amboy Street Ventures is a New York-based venture capital firm focused on backing startups that lift stigma and close innovation gaps in sexual and women's health. Their focus spans femtech, consumer health brands, telehealth, and diagnostics across the United States, Canada, and Europe. Founded by Carli Sapir with a $20M debut fund, the firm supports founders at seed and Series A with roughly $500K checks.

Min check size: $100K
Max check size: $2M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Amboy Street Ventures is a seed to Series A venture capital firm deploying capital across sexual health technology, women's health technology, femtech, and consumer health. They invest across six defined verticals: maternal health and fertility, hormonal health and menstruation, menopause and aging, abortion and contraception, LGBTQIA+ health and gender-affirming care, and sexual health and pleasure. The firm differentiates itself as the first VC fund dedicated to the sexual health and women's health category, backed by a dedicated Value Enhancement Team operating within the Healthy Pleasure Group ecosystem.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Founded in 2020 by Carli Sapir (Founding Partner, based in Amsterdam) and Devrim Selim (Founding Partner). World's first VC firm dedicated to sexual health and women's health tech across US and Europe. Fund I closed at $10M in 2023. Portfolio includes Bloomer Tech, Peppy, Ossio, EvoEndo, and Vessel Health.